Omega-3状态与脓毒症住院长期风险的关联
该研究基于英国生物银行273325名参与者的回顾性人群队列数据,分析基线估算omega-3指数(eO3I)与脓毒症住院风险的关系。中位基线eO3I为6.0%(4.8-7.3%),平均随访13年期间9241人因脓毒症住院。校正模型中,与最低eO3I四分位相比,第二、第三、第四四分位的脓毒症发生风险分别为HR 0.88(95%CI 0.86-0.91,p<0.001)、HR 0.80(95%CI 0.78-0.83,p<0.001)、HR 0.75(95%CI 0.73-0.77,p<0.001);连续变量分析中eO3I升高与脓毒症风险降低相关(p<0.001)。作者认为omega-3水平可通过膳食补充提高,应探索一级预防以减轻脓毒症负担。
要点
- 英国生物银行273325名参与者,平均随访13年,9241人因脓毒症住院,中位基线eO3I为6.0%(4.8-7.3%)。
- 与最低eO3I四分位相比,第二四分位脓毒症住院风险HR 0.88(95%CI 0.86-0.91,p<0.001)。
- 第三四分位脓毒症住院风险HR 0.80(95%CI 0.78-0.83,p<0.001),第四四分位HR 0.75(95%CI 0.73-0.77,p<0.001)。
- 连续变量分析中,eO3I升高与脓毒症风险降低相关(p<0.001)。
- 作者认为omega-3水平可通过膳食补充提高,应探索一级预防以减轻脓毒症负担。
适用人群与场景
- 英国生物银行273325名参与者,回顾性人群队列数据。
- 暴露为基线估算omega-3指数(eO3I),结局为带国际疾病分类第10版脓毒症相关编码的住院。
研究设计与关键结果
- 研究设计:基于英国生物银行的人群队列研究,273325名参与者,暴露为基线eO3I(按四分位分类及限制性立方样条连续建模),结局为脓毒症相关住院。
- 中位(四分位距)基线eO3I为6.0%(4.8-7.3%);平均随访13年期间9241名参与者因脓毒症住院。
- 校正模型中,与最低eO3I四分位相比,第二四分位脓毒症发生风险HR 0.88(95%CI 0.86-0.91,p<0.001)。
- 第三四分位脓毒症发生风险HR 0.80(95%CI 0.78-0.83,p<0.001)。
- 第四四分位脓毒症发生风险HR 0.75(95%CI 0.73-0.77,p<0.001)。
- 连续变量分析中,eO3I升高与脓毒症风险降低相关(p<0.001)。
证据类型、等级与局限
- 证据类型:基于英国生物银行的回顾性人群队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,鉴于omega-3水平可通过膳食补充提高,应探索一级预防以减轻脓毒症负担。
- 本研究为观察性队列,基线eO3I与脓毒症住院风险的负相关不能直接转化为急诊或ICU补充omega-3的推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Sepsis is a life-threatening condition characterized by a dysregulated host response to infection. Despite decades of clinical trials, there are no specific treatments; care of the nearly 50 million annual cases worldwide is limited to antimicrobials and supportive measures. A primary prevention strategy may therefore be of value. We hypothesized that higher premorbid omega-3 fatty acid levels would be associated with a reduced incidence of sepsis.
DESIGN: Population-based cohort study.
SETTING: Retrospective data from the United Kingdom (U.K. Biobank).
PATIENTS: Two hundred seventy-three thousand three hundred twenty-five participants from the U.K. Biobank.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Our exposure was baseline estimated omega-3 index (eO3I), modeled both categorically in quartiles, and continuously with restricted cubic splines. Our outcome measure was hospital admission with an International Classification of Diseases , 10th Edition code consistent with sepsis. The median (interquartile range) baseline eO3I was 6.0% (4.8-7.3%). Over a mean follow-up period of 13 years, 9241 participants experienced hospitalization with sepsis. In our adjusted model, compared with the lowest eO3I quartile, participants had lower risks of sepsis incidence in the second quartile (hazard ratio [HR], 0.88; 95% CI, 0.86-0.91; p < 0.001), third quartile (HR, 0.80; 95% CI, 0.78-0.83; p < 0.001), and fourth quartile (HR, 0.75; 95% CI, 0.73-0.77; p < 0.001). When analyzed as a continuous variable, increasing eO3I was associated with a decreasing risk of sepsis ( p < 0.001).
CONCLUSIONS: In this population-based cohort study, baseline eO3I was inversely associated with subsequent sepsis incidence. Given that omega-3 levels can be increased with dietary supplementation, primary prevention should be explored to mitigate the burden of sepsis.
参考来源
- Narayan D, Vlasschaert C, Day AG, et al. Association of Omega-3 Status With Long-Term Risk of Hospitalization for Sepsis. Crit Care Med. 2025. PMID: 39898761. doi:10.1097/CCM.0000000000006593
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。